28th January 2025 (Tuesday)
At 6:00 PM CST
This 90-minute webinar explores the latest advancements in atrial fibrillation (AF) ablation technologies, spotlighting two transformative innovations. Cryoablation has treated over 1.4 million patients globally, earning its place as the gold standard in AF treatment due to its safety, efficacy, and accessibility. Its independence from mapping ensures efficiency and widespread applicability.
Pulse Field Ablation (PFA) is redefining AF management with its precision, safety, and versatility. Innovations like Sphere-9 integrate mapping and ablation, streamlining workflows and improving patient outcomes. This session will provide valuable insights into how these technologies are shaping clinical guidelines, advancing tailored AF treatments, and addressing the growing demand for effective and efficient care.
The webinar aims to equip participants with a deeper understanding of Cryoablation and Pulse Field Ablation technologies. Attendees will gain insights into the clinical benefits, safety, and accessibility of Cryoablation, as well as the cutting-edge precision and versatility of PFA and its tools like Sphere-9. The session will also examine how these technologies are driving improvements in guidelines, outcomes, and personalized approaches to AF management, offering participants actionable strategies to integrate these innovations into their practice.
Cryoablation: Proven safety and efficacy with over 1.4 million patients treated globally; independence from mapping for broad accessibility.
Pulse Field Ablation (PFA): Exceptional precision and safety, featuring innovations like Sphere-9 that integrate mapping and ablation.
Clinical Impact: How these technologies are reshaping clinical guidelines and advancing personalized AF treatment strategies.
Expert Discussions: Practical insights into integrating these technologies into routine clinical practice for enhanced outcomes.